Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Cosmet Dermatol ; 21(5): 1986-1988, 2022 May.
Article in English | MEDLINE | ID: mdl-35176192

ABSTRACT

A novel fractional laser system with differential-wavelength modified optically pumped semiconductor technology can produce a pure 585 nm wavelength as pulsed dye laser, which has been used to treat vascular, pigmented skin lesions. Besides, this new laser modality also showed promising results for verruca plana in our experience. In this brief report, we present three cases of facial flat warts treated by this novel 585 nm diode laser.


Subject(s)
Lasers, Dye , Lasers, Solid-State , Warts , Face , Humans , Lasers, Dye/therapeutic use , Lasers, Semiconductor/therapeutic use , Lasers, Solid-State/therapeutic use , Treatment Outcome , Warts/surgery
3.
Acta Derm Venereol ; 85(3): 236-9, 2005.
Article in English | MEDLINE | ID: mdl-16040409

ABSTRACT

Tazarotene and calcipotriol are both effective in the treatment of psoriasis. An investigator-blind, bilateral comparison of 44 lesion pairs in 19 patients was conducted to evaluate the efficacy, side effects and duration of therapeutic effects of once-daily tazarotene 0.1% gel plus petrolatum with twice-daily calcipotriol 0.005% ointment in plaque psoriasis. It consisted of a 12-week treatment phase, followed by a 4-week post-treatment observation phase. At the end of the treatment phase, tazarotene-petrolatum was as effective as calcipotriol in both objective and subjective overall efficacy assessment. Calcipotriol had a significantly greater effect in reducing erythema than tazarotene-petrolatum at weeks 2-8. At week 16, tazarotene-petrolatum demonstrated a significantly better maintenance effect in all parameters. Local irritation was noted only in tazarotene-petrolatum-treated lesions. Once-daily tazarotene 0.1% gel plus petrolatum was as effective as twice-daily calcipotriol 0.005% ointment in the treatment of plaque psoriasis, but had a better maintenance effect after the cessation of therapy.


Subject(s)
Calcitriol/analogs & derivatives , Dermatologic Agents/administration & dosage , Nicotinic Acids/administration & dosage , Psoriasis/drug therapy , Administration, Cutaneous , Adolescent , Adult , Aged , Aged, 80 and over , Calcitriol/administration & dosage , Child , Double-Blind Method , Drug Administration Schedule , Female , Gels , Humans , Male , Middle Aged , Ointments , Petrolatum/administration & dosage , Prospective Studies , Psoriasis/pathology , Severity of Illness Index , Treatment Outcome
4.
Clin Immunol ; 117(1): 65-72, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16043414

ABSTRACT

The aim of this study was to investigate the expression of interleukin-20 (IL-20) and its receptors on psoriatic skin by immunohistochemical analysis and to evaluate the correlation of CD8-positive T lymphocytes with epidermal proliferation. Overexpression of IL-20 and its receptors was detected in the keratinocytes of the lesional skin of psoriasis and spongiotic dermatitis. The expression pattern of IL-20 spreads throughout the whole layer of epidermis, while IL-19 was expressed in up to three or four layers suprabasally. The serum level of IL-20 in psoriatic patients was significantly lower than that in healthy controls. IL-20 upregulated KGF transcripts on CD8-positive T cells. We hypothesize that overexpression of IL-20 is correlated with keratinocyte proliferation that acts through their receptor complex expressed by keratinocytes themselves. Furthermore, IL-20 can stimulate CD8-positive lymphocytes to produce KGF, which may contribute to sustaining the hyperproliferative status of the keratinocytes.


Subject(s)
Interleukins/metabolism , Psoriasis/metabolism , Receptors, Interleukin/metabolism , Skin/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Fibroblast Growth Factor 7 , Fibroblast Growth Factors/immunology , Fibroblast Growth Factors/metabolism , Humans , Immunohistochemistry , Interleukin-10/immunology , Interleukin-10/metabolism , Interleukins/blood , Interleukins/immunology , Keratinocytes/immunology , Keratinocytes/metabolism , Psoriasis/blood , Psoriasis/immunology , Receptors, Interleukin/immunology , Reverse Transcriptase Polymerase Chain Reaction , Skin/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...